Drug Shortage Report for ODAN-SODIUM POLYSTYRENE SULFONATE
| Report ID | 103222 |
| Drug Identification Number | 02473968 |
| Brand name | ODAN-SODIUM POLYSTYRENE SULFONATE |
| Common or Proper name | Sodium Polystyrene Sulfonate Oral/Rectal Suspension |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
| Strength(s) | 250MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL RECTAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 60 mL |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2020-01-13 |
| Actual start date | 2020-01-13 |
| Estimated end date | 2022-01-30 |
| Actual end date | 2022-06-02 |
| Shortage status | Resolved |
| Updated date | 2022-06-07 |
| Company comments | Delay in testing of the drug |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | [email protected] Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-01-13 | English | Compare |